We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
93 hedge funds and large institutions have $152M invested in CTI BioPharma Corp. (DE) Common Stock in 2014 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 34 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
138% more capital invested
Capital invested by funds: $63.7M → $152M (+$87.8M)
70% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 20
22% more funds holding
Funds holding: 76 → 93 (+17)
73% less call options, than puts
Call options by funds: $2.32M | Put options by funds: $8.66M
Holders
93
Holders Change
+17
Holders Change %
+22.37%
% of All Funds
2.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
34
Reduced
20
Closed
8
Calls
$2.32M
Puts
$8.66M
Net Calls
-$6.34M
Net Calls Change
+$493K
Top Buyers
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$23M |
| 2 |
State Street
Boston,
Massachusetts
|
+$16.5M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$4.62M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.27M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.42M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.95M |
| 2 |
PA
Perceptive Advisors
New York
|
-$7.13M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.34M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.42M |
| 5 |
Goldman Sachs
New York
|
-$1.37M |
